InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Pott, Amy. Insider active across 2 companies, notably enGene Therapeutics Inc.. Aggregated, 6 filings have been published. Activity tracked since 16 June 2026. The latest transaction was disclosed on 25 June 2026 (50 - Grant of options). Regulator: SEDI. All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Amy Pott is a declarant linked to 6 filings in total. In the 6 sampled recent filings, no buy or sell volume is indicated, and the period runs from 2026-06-19 to 2026-06-30; the top filings relate to Eupraxia Pharmaceuticals Inc. and enGene Therapeutics Inc., with amounts of EUR 219974.1638660431 and EUR 215530.0080776215.